Darunavir (Prezista)

Published August 09, 2006; Updated October 2016
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-10
Selected Reference
4. Lennox JL, Landovitz RJ, Ribaudo HJ, et al; ACTG A5257 Team. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med. 2014 Oct 7;161(7):461-71.